Patent · US Active

Methods for diagnosing systemic lupus erythematosus

US7910299B2 · kind B2 · utility

0Cited by
5References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 3, 2006
Grant dateMar 22, 2011
Priority date
Expiry dateApr 23, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to methods and materials involved in diagnosing SLE. More particularly, the invention relates to methods and materials involved in diagnosing SLE, diagnosing severe SLE, and assessing a mammal's susceptibility to develop severe SLE. For example, the invention provides nucleic acid arrays that can be used to diagnose SLE in a mammal. Such arrays can allow clinicians to diagnose SLE based on a simultaneous determination of the expression levels of many genes that are differentially expressed in SLE patients as compared to healthy controls.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.